Matches in Nanopublications for { ?s ?p "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP268049.RAV5R32ZfUJNaXcL5RZQk8awagpZVVIMivrrWKiXK6iBg130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268049.RAV5R32ZfUJNaXcL5RZQk8awagpZVVIMivrrWKiXK6iBg130_provenance.
- NP564999.RAYOMMr9_CUoTBEvA7uGPAsdImEELVE5o0_qduCq9AaSY130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564999.RAYOMMr9_CUoTBEvA7uGPAsdImEELVE5o0_qduCq9AaSY130_provenance.
- assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP375449.RANr_iB4iCzjfVcg0jQQ-834w-UEEb6_VFRQuCOKKsfnM130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375449.RANr_iB4iCzjfVcg0jQQ-834w-UEEb6_VFRQuCOKKsfnM130_provenance.
- NP610883.RAbr0sf1Pr159PATXbi-9L_zZdkDuO67rhgsih70IVe9M130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610883.RAbr0sf1Pr159PATXbi-9L_zZdkDuO67rhgsih70IVe9M130_provenance.
- NP610886.RAj-y9XRkWGiJEqafyJPwSmwx-yhamF8VOJvfjWHGWXyk130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610886.RAj-y9XRkWGiJEqafyJPwSmwx-yhamF8VOJvfjWHGWXyk130_provenance.
- NP383804.RAL3IMMHunT0S2WM1B4iBnJIU-emiUQ1sw4GZ-ll6z3s0130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383804.RAL3IMMHunT0S2WM1B4iBnJIU-emiUQ1sw4GZ-ll6z3s0130_provenance.
- NP610885.RAJO5lz29tDHfkMedHysJWvlBVRmB0IsblERcJ1XrbvHI130_assertion description "[It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610885.RAJO5lz29tDHfkMedHysJWvlBVRmB0IsblERcJ1XrbvHI130_provenance.